Legal Representation
Attorney
Bassam N. Ibrahim
USPTO Deadlines
Application History
9 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jun 5, 2013 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Nov 18, 2011 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Nov 18, 2011 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Apr 20, 2011 | GEAN | O | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | Loading... |
| Apr 20, 2011 | GEAP | F | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | Loading... |
| Apr 20, 2011 | CPEA | R | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | Loading... |
| Apr 14, 2011 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 11, 2011 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 11, 2011 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals for the treatment of macular edema, macular disease, retinal disease, glaucoma, and ocular allegry
First Use Anywhere:
0
First Use in Commerce:
0
Class 010
Sustained drug delivery systems for ocular drugs
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Translation
The wording "ILUVIEN" has no meaning in a foreign language.
Classification
International Classes
005
010